Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04174963 · ClinicalTrials.gov registry record · NA
An Electronic Intervention to Reduce Cannabis Among Young Adults in Psychiatric Care
A NA study, sponsored by Rhode Island Hospital.
- Terminated
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT04174963 is a NA study that was terminated before completion, run by Rhode Island Hospital. The registered enrollment target is 12 participants.
The verdict
NCT04174963, a NA study, was terminated before completion, sponsored by Rhode Island Hospital.
- TERMINATED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
Cannabis use disorders are common among young adults in psychiatric treatment. Unfortunately, cannabis use can result in deleterious consequences for those in treatment, including developing more severe psychopathology and poorer treatment outcomes. Brief, electronic interventions for cannabis use have been developed for young adults. An example of a frequently used brief electronic intervention for cannabis users is e-Toke. e-Toke can be completed on a computer, tablet or phone, and has been shown to improve motivation to engage in substance use treatment among college students. However, e-Toke is less useful in decreasing the actual frequency of cannabis use. Additionally, e-toke is not tailored to young adults in psychiatric treatment. In this study, the investigators will develop and test a text messaging intervention that can be easily added to the popular computerized intervention e-Toke. The research staff hope the intervention will improve motivation to decrease cannabis use, and decrease the frequency of cannabis use, among young adults in psychiatric outpatient treatment. The text messages will be developed by, and tailored to, young adults in psychiatric treatment and texts will address motivations and barriers to reducing cannabis use in the context of psychiatric disorders. If the text message intervention is found to be an effective addition to e-Toke, this approach can be tested in a larger study, and then disseminated to other young adults in psychiatric treatment.
Interventions
- BEHAVIORAL eToke + TPsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2019-11-01 |
| Est. Completion | 2022-05-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04174963
The ClinicalTrials.gov registry entry for NCT04174963 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rhode Island Hospital, which has 130 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which eToke + TPsy is the first listed.
NCT04174963 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04174963 about?
NCT04174963 is a clinical study titled "An Electronic Intervention to Reduce Cannabis Among Young Adults in Psychiatric Care". Cannabis use disorders are common among young adults in psychiatric treatment. Unfortunately, cannabis use can result in deleterious consequences for those in treatment, including developing more severe psychopathology and poorer treatment outcomes. Brief, electronic interventions for cannabis use h...
What is the current status of trial NCT04174963?
This trial is currently terminated. It is a NA study. The enrollment target is 12 participants. The study started on 2019-11-01. Estimated completion is 2022-05-24.
What interventions are being tested in trial NCT04174963?
The interventions under investigation include: eToke + TPsy (BEHAVIORAL).
Who is sponsoring clinical trial NCT04174963?
This trial is sponsored by Rhode Island Hospital, which has 130 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.